Aktieanalys

Vicore: Initiates Blood Flow Study with C21 - Redeye

{newsItem.title}

Redeye Publicerad: 18 Mar 2022 12:37

We give a brief comment on the new clinical study with Vicore’s C21.

Länk till analysen i sin helhet: https://www.redeye.se/research/836621/vicore-initiates-blood-flow-study-with-c21?utm_source=finwire&utm_medium=RSS

Nyheter om Vicore Pharma

Läses av andra just nu

Om aktien Vicore Pharma

Senaste nytt